Review Article
The Role of Obesity in the Poor Prognosis of COVID-19 Infection: A Review of 192 Patients
Table 1
Population characteristics, based on BMI class (n = 192).
| Patient characteristics | BMI < 25 (n = 46) 24% | 25 ≤ BMI < 30 (n = 71) 37% | 30 ≤ BMI < 35 (n = 54) 28.1% | BMI ≥ 35 (n = 21) 10.9% | Total (n = 192) |
| Age (years) | 60.15 [18.74] | 64.56 [13.02] | 62.72 [13.95] | 61.81 [17.48] | 62.68 [19–96] | Male sex | 24 (52%) | 46 (64.8%) | 41 (75.9%) | 13 (61.9%) | 124 (64.58%) | Weight (kg) | 63.8 [1.62] | 79.86 [11] | 90.76 [11.23] | 108.3 [19.21] | 82.19 [37–157] | Height (m) | 1.69 [0.09] | 1.70 [0.11] | 1.69 [0.10] | 1.67 [0.11] | 1.69 [0.10] | Smoking | 12 (26.1%) | 16 (22.5%) | 14 (25.9%) | 6 (28.6%) | 50 (26.04%) | Diabetes | 10 (21.7%) | 23 (32.39%) | 16 (29.6%) | 7 (33.3%) | 56 (29.17%) | Hypertension | 23 (50%) | 43 (60.6%) | 34 (63%) | 14 (66.7%) | 114 (59.38%) | Dyslipidemia | 18 (39.1%) | 32 (45.1%) | 21 (38.9%) | 8 (38.1%) | 79 (41.1%) |
|
|